Cargando…
1147. Short Course of Voriconazole Therapy as a Risk Factor for Relapse of Invasive Pulmonary Aspergillosis
BACKGROUND: Invasive pulmonary aspergillosis (IPA) is a life-threatening opportunistic infection which usually occurs in immunocompromised patients. Recommended duration of voriconazole therapy is a minimum of 6-12 weeks for IPA, despite the lack of any firm evidence. In addition, risk factors for r...
Autores principales: | Shin, Dong Hoon, Yoo, Seung-Jin, Jung, Jongtak, Jun, Kang Il, Kim, Hyungjin, Kang, Chang Kyung, Song, Kyung Ho, Choe, Pyoeng Gyun, Park, Wan Beom, Bang, Ji-Hwan, Kim, Eu Suk, Park, Sang Won, Kim, Hong Bin, Kim, Nam-Joong, Oh, Myoung-don |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777351/ http://dx.doi.org/10.1093/ofid/ofaa439.1333 |
Ejemplares similares
-
Short course of voriconazole therapy as a risk factor for relapse of invasive pulmonary aspergillosis
por: Shin, Dong Hoon, et al.
Publicado: (2020) -
813. The Reduction of the acquisition rate of carbapenem resistant Acinetobacter baumannii after room privatization in the intensive care unit
por: Jung, Jongtak, et al.
Publicado: (2020) -
Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection
por: Choe, Pyoeng Gyun, et al.
Publicado: (2021) -
Changes in Anxiety Level and Personal Protective Equipment Use Among Healthcare Workers Exposed to COVID-19
por: Park, Do Hyeon, et al.
Publicado: (2022) -
Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients
por: Choe, Pyoeng Gyun, et al.
Publicado: (2020)